Valuation: Viatris Inc.

Market Cap 18.64B 16.1B 15.13B 13.76B 25.87B 1,783B 26.3B 177B 69.31B 893B 69.99B 68.47B 2,966B P/E 2026 *
77.1x
P/E 2027 * 30.6x
Enterprise Value 30.71B 26.52B 24.92B 22.67B 42.61B 2,936B 43.31B 292B 114B 1,470B 115B 113B 4,886B EV / Sales 2026 *
2.08x
EV / Sales 2027 * 1.98x
Free-Float
91.44%
Yield 2026 *
3.13%
Yield 2027 * 3.22%
1 day-0.40%
1 week-0.71%
Current month-7.94%
1 month-6.51%
3 months-2.03%
6 months+2.70%
Current year+29.84%
1 week 15.88
Extreme 15.88
16.56
1 month 15.88
Extreme 15.88
18.39
Current year 12.19
Extreme 12.19
18.39
1 year 9.42
Extreme 9.425
18.39
3 years 6.85
Extreme 6.85
18.39
5 years 6.85
Extreme 6.85
18.39
10 years 6.85
Extreme 6.85
49.42
Manager TitleAgeSince
Chief Executive Officer 63 01/04/2023
Director of Finance/CFO 59 08/05/2026
Chief Tech/Sci/R&D Officer - 15/12/2023
Director TitleAgeSince
Director/Board Member 78 16/11/2020
Director/Board Member 78 16/11/2020
Director/Board Member 62 16/11/2020
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Free

Director

2,756 0.0002%
30/06/26 Free

Director

2,362 0.0002%
06/03/26 Fiscal year

Chief Financial Officer

127,364 0.0111%
Change 5-day change 1-year change 3-year change Capi.($)
-0.34%-0.71%+52.07%+42.55% 18.64B
+1.07%-2.81%+71.52%+122.69% 1,052B
+1.20%+0.72%+49.61%+51.53% 627B
+0.38%+1.22%+21.50%+67.30% 441B
+0.28%-4.56%+39.10%+38.05% 349B
+0.78%-2.68%+23.13%+37.32% 287B
+0.87%-3.59%-1.52%+7.12% 241B
+0.61%+0.17%+42.81%+58.38% 224B
-0.78%-4.49%-15.86%-54.13% 202B
+0.10%+4.08%+17.38%+81.04% 172B
Average +0.29%-0.82%+29.98%+45.19% 361.38B
Weighted average by Cap. +0.61%-0.63%+40.44%+64.66%

Financials

2026 *2027 *
Net sales 14.78B 12.77B 12B 10.91B 20.51B 1,414B 20.85B 141B 54.96B 708B 55.5B 54.29B 2,352B 15.03B 12.98B 12.2B 11.09B 20.86B 1,437B 21.2B 143B 55.88B 720B 56.42B 55.2B 2,391B
Net income -27.26M -23.54M -22.12M -20.12M -37.83M -2.61B -38.45M -259M -101M -1.31B -102M -100M -4.34B 340M 294M 276M 251M 472M 32.5B 479M 3.23B 1.26B 16.27B 1.28B 1.25B 54.08B
Net Debt 12.07B 10.42B 9.79B 8.91B 16.74B 1,154B 17.02B 115B 44.86B 578B 45.3B 44.32B 1,920B 11.08B 9.57B 8.99B 8.18B 15.37B 1,059B 15.63B 105B 41.19B 531B 41.6B 40.69B 1,763B
Logo Viatris Inc.
Viatris Inc. is a global healthcare company. The Company markets branded and generic drugs, including complex drugs. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Company's Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The Company's JANZ segment consists of its operations in Japan, Australia and New Zealand. Its Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. It produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a variety of noncommunicable and infectious diseases.
Employees
30,000
Date Price Change Volume
17/08/26 $16.15 -0.49% 1,557,754
14/08/26 $16.23 +1.18% 8,202,731
13/08/26 $16.04 -0.37% 16,157,284
12/08/26 $16.10 -1.11% 13,605,624
11/08/26 $16.28 0.00% 12,758,893
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
16.23USD
Average target price
18.50USD
Spread / Average Target
+13.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VTRS Stock